Align Technology, Inc. (0HCK.L)
USD 181.9
(4.2%)
USD 181.9
(4.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.72 Billion USD | 2.64% |
| 2022 | 2.65 Billion USD | -10.27% |
| 2021 | 2.95 Billion USD | 66.32% |
| 2020 | 1.77 Billion USD | 1.11% |
| 2019 | 1.75 Billion USD | 20.06% |
| 2018 | 1.46 Billion USD | 30.14% |
| 2017 | 1.12 Billion USD | 37.06% |
| 2016 | 820.18 Million USD | 28.13% |
| 2015 | 640.11 Million USD | 10.66% |
| 2014 | 578.44 Million USD | 16.13% |
| 2013 | 498.1 Million USD | 19.42% |
| 2012 | 417.08 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 685.56 Million USD | -5.13% |
| 2024 Q1 | 703.26 Million USD | 4.43% |
| 2024 Q2 | 722.62 Million USD | 2.75% |
| 2023 Q4 | 673.44 Million USD | 0.82% |
| 2023 FY | 2.72 Billion USD | 2.83% |
| 2023 Q1 | 665.18 Million USD | 6.81% |
| 2023 Q2 | 718.49 Million USD | 8.01% |
| 2023 Q3 | 667.98 Million USD | -7.03% |
| 2022 Q4 | 622.77 Million USD | -0.02% |
| 2022 Q3 | 622.86 Million USD | -9.95% |
| 2022 FY | 2.65 Billion USD | -10.27% |
| 2022 Q1 | 712.88 Million USD | -4.13% |
| 2022 Q2 | 691.68 Million USD | -2.97% |
| 2021 Q3 | 759.62 Million USD | -0.47% |
| 2021 Q4 | 743.62 Million USD | -2.11% |
| 2021 Q1 | 677.09 Million USD | 10.92% |
| 2021 Q2 | 763.19 Million USD | 12.72% |
| 2021 FY | 2.95 Billion USD | 66.32% |
| 2020 Q1 | 394.35 Million USD | -16.44% |
| 2020 Q3 | 534.08 Million USD | 138.08% |
| 2020 FY | 1.77 Billion USD | 1.11% |
| 2020 Q4 | 610.46 Million USD | 14.3% |
| 2020 Q2 | 224.32 Million USD | -43.12% |
| 2019 FY | 1.75 Billion USD | 20.06% |
| 2019 Q4 | 471.95 Million USD | 7.86% |
| 2019 Q3 | 437.55 Million USD | 1.22% |
| 2019 Q1 | 402.09 Million USD | 4.96% |
| 2019 Q2 | 432.28 Million USD | 7.51% |
| 2018 Q2 | 365.58 Million USD | 11.66% |
| 2018 Q1 | 327.4 Million USD | 2.99% |
| 2018 FY | 1.46 Billion USD | 30.14% |
| 2018 Q4 | 383.09 Million USD | 3.04% |
| 2018 Q3 | 371.78 Million USD | 1.7% |
| 2017 Q4 | 317.91 Million USD | 8.69% |
| 2017 Q1 | 235.62 Million USD | 6.98% |
| 2017 FY | 1.12 Billion USD | 37.06% |
| 2017 Q2 | 270.91 Million USD | 14.98% |
| 2017 Q3 | 292.48 Million USD | 7.96% |
| 2016 Q2 | 205.21 Million USD | 13.61% |
| 2016 Q1 | 180.62 Million USD | 4.52% |
| 2016 Q3 | 209.2 Million USD | 1.94% |
| 2016 FY | 820.18 Million USD | 28.13% |
| 2016 Q4 | 220.24 Million USD | 5.28% |
| 2015 Q2 | 158.63 Million USD | 4.99% |
| 2015 Q4 | 172.81 Million USD | 9.67% |
| 2015 FY | 640.11 Million USD | 10.66% |
| 2015 Q3 | 157.57 Million USD | -0.67% |
| 2015 Q1 | 151.09 Million USD | 0.28% |
| 2014 FY | 578.44 Million USD | 16.13% |
| 2014 Q2 | 145.47 Million USD | 5.99% |
| 2014 Q1 | 137.25 Million USD | 0.57% |
| 2014 Q4 | 150.66 Million USD | 3.87% |
| 2014 Q3 | 145.05 Million USD | -0.29% |
| 2013 Q2 | 123.69 Million USD | 9.61% |
| 2013 FY | 498.1 Million USD | 19.42% |
| 2013 Q1 | 112.84 Million USD | 5.19% |
| 2013 Q3 | 125.09 Million USD | 1.13% |
| 2013 Q4 | 136.47 Million USD | 9.1% |
| 2012 Q4 | 107.27 Million USD | 0.0% |
| 2012 FY | 417.08 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1248.317% |
| Accuray Incorporated | 143.12 Million USD | -1800.604% |
| Elevance Health Inc. | 47.01 Billion USD | 94.214% |
| AxoGen, Inc. | 127.87 Million USD | -2027.221% |
| Boston Scientific Corporation | 9.84 Billion USD | 72.381% |
| CVS Health Corporation | 54.43 Billion USD | 95.003% |
| Cardinal Health, Inc. | 7.41 Billion USD | 63.31% |
| Centene Corporation | 153.99 Billion USD | 98.234% |
| DaVita Inc. | 3.82 Billion USD | 28.8% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 95.06% |
| Hologic, Inc. | 2.23 Billion USD | -21.555% |
| Humana Inc. | 106.44 Billion USD | 97.444% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -24.21% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 19.161% |
| Masimo Corporation | 1 Billion USD | -171.068% |
| McKesson Corporation | 12.58 Billion USD | 78.384% |
| Patterson Companies, Inc. | 1.38 Billion USD | -97.079% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 8.134% |
| ResMed Inc. | 2.6 Billion USD | -4.269% |
| Henry Schein, Inc. | 3.65 Billion USD | 25.495% |
| Teladoc Health, Inc. | 1.84 Billion USD | -47.644% |
| Universal Health Services, Inc. | 1.17 Billion USD | -131.428% |
| Veeva Systems Inc. | 1.68 Billion USD | -61.302% |
| Baxter International Inc. | 4.97 Billion USD | 45.323% |
| Becton, Dickinson and Company | 8.82 Billion USD | 69.17% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 42.485% |
| Danaher Corporation | 14.12 Billion USD | 80.748% |
| Stryker Corporation | 13.05 Billion USD | 79.169% |
| Medtronic plc | 21.27 Billion USD | 87.213% |